Renaissance Capital logo

RCBC News

US IPO Weekly Recap: August kicks off with flurry of biotech IPOs

BRVE

Six IPOs and five SPACs priced this week. Two IPOs and eight SPACs submitted filings. Cardiovascular disease biotech Braveheart Bio (BRVE) upsized and priced above the range, raising $383 million at a $1.6 billion market cap. Its lead candidate, BHB-1893, is ...read more

California-based River City Bank prices downsized IPO at $45, below the range

River City Bank logo

River City Bank, a California-based commercial bank, raised $122 million by offering 2.7 million shares (100% secondary) at $45, below the $48 to $51 range. The offering contained 50 thousand fewer shares than anticipated. River City Bank states that it is...read more

US IPO Week Ahead: August IPO market opens with biotechs, a bank, and SpaceX earnings

SPCX

Updated Monday, 8/3. Six IPOs are currently scheduled for the week ahead, featuring five biotechs and a California bank. Mega-issuer SpaceX (SPCX) will also be in focus as it reports earnings for the first time as a public company ahead of a partial lock-up...read more

California-based River City Bank sets terms for $136 million Nasdaq IPO

River City Bank logo

River City Bank, a California-based commercial bank, announced terms for its Nasdaq IPO. The Sacramento, CA-based company plans to raise $136 million by offering 2.75 million shares (100% secondary) at a price range of $48 to $51. At the midpoint of the...read more

Archived Headlines